In what was billed as a breakthrough, the Swiss regulator, with WHO, approved Coartem Baby (Riamet Baby) — a sweet, dissolvable antimalarial tablet for newborns and infants (2–5 kilogrammes). Uganda is already fast-tracking clinical guideline updates and distribution.
It is a big deal because tailored paediatric medicine not only saves more lives, but also shows how innovation can meet Africa’s health emergencies.
